The Institute for Microbial Biotechnology and Metagenomics (IMBM) is a leading research unit based within the Department of Biotechnology at the University of the Western Cape (UWC). The Institute is a global competitor in microbial biotechnology and metagenomics, and is committed to excellence in research and in the training of future research leaders. Its research encompasses a number of disciplines including microbiology, (meta)genomics, molecular biology, enzymology and bioinformatics, and employs culture-based approaches as well as cutting edge ”omics” strategies.

Description of Research:
As part of 2 EU-funded consortia (PharmaSea and Ocean Medicines) we are focusing on novel secondary metabolite pathways from bacteria associated with marine invertebrates and sediments. Extract preparations from these isolates have shown anti-convulsant, anti-microbial or anti-inflammatory properties. Through genome sequencing and genetic engineering strategies in parallel with chemistry-guided isolation, we would like to link novel metabolites to the biosynthetic pathways encoding them.

Academic criteria:
Applicants must have completed a PhD degree within no more than 5 years in a foundational discipline relevant to the topic. Applicants should have a strong publication record, interpersonal skills, project management experience, and be able to effectively conduct research as part of a multi-disciplinary team.

THE CLOSING DATE FOR APPLICATIONS IS 28 FEBRUARY 2017